Ginkgo Bioworks Holdings (DNA) Capital Leases (2020 - 2022)

Ginkgo Bioworks Holdings (DNA) has 3 years of Capital Leases data on file, last reported at $59.8 million in Q3 2022.

• Quarterly Capital Leases rose 267.85% year-over-year to $59.8 million in Q3 2022, while the trailing twelve-month figure through Sep 2022 was $59.8 million (up 267.85% YoY) and the FY2021 annual result came in at $22.3 million, up 34.9% from the prior year.
• Capital Leases grew to $59.8 million in Q3 2022, from $51.5 million in the prior quarter.
• In the past five years, Capital Leases ranged from a high of $59.8 million in Q3 2022 to a low of $16.3 million in Q3 2021.
• A 3-year average of $32.3 million and a median of $24.8 million in 2021 frame the typical range for Capital Leases.
• Annual changes were most pronounced in 2021 — Capital Leases soared 34.9% — and 2022, when it jumped 267.85%.
• Tracing DNA's Capital Leases over 3 years: stood at $16.5 million in 2020, then surged by 34.9% to $22.3 million in 2021, then surged by 168.55% to $59.8 million in 2022.
• The last three Capital Leases figures came in at $59.8 million (Q3 2022), $51.5 million (Q2 2022), and $27.3 million (Q1 2022), per Business Quant data.